Gelişiyor
Sağlık·evvelsi günAI özeti
India Approves Takeda's QDENGA Dengue Vaccine
India's Drug Controller General of India (DCGI) has approved Takeda's QDENGA, the country's first dengue vaccine, for individuals aged 4 to 60. The two-dose vaccine protects against all four dengue virus serotypes and can be administered regardless of previous infection, with launch expected in H1 2027.
T
Times of India2 dk okuma
